HealthTech company focused on early detection of breast cancer, Volpara Health (ASX: VHT), has reported a fourth consecutive positive net operating cash flow quarter. As a result, it does not have to submit quarterly ASX updates anymore. What’s better, the Company surpassed its initial guidance by a year and a half. For the quarter ended
Read More
As medical technology continues to advance, digital imaging is now a staple for image interpretation for cancer diagnosis, especially in finding potential abnormalities that aren’t visible to the eyes as well as evaluating the extent of the disease. Breast cancer software company Volpara (ASX: VHT) is among those that offers what it takes to meet
Read More
Artificial intelligence biotech company Volpara Health (ASX: VHT) has started the year by raking in the money (is there a better way?), and shareholders are here for it. Volpara has signed five contracts worth $11.34 million (NZ$12.3 million) combined. The five-year contracts include some leading US healthcare companies, including Bon Secours Mercy Health, Northside Hospital,
Read More
At a time when women are more aware of potential health issues than ever, Volpara Health (ASX: VHT) is set to drastically improve how breast cancer is talked about with imaging technology driven by artificial intelligence that will help prevent advanced stage breast cancer. The imagery will be provided to women in collaboration with Sheila
Read More